Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

Conditions studied

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Negative Breast Carcinoma, Triple-Negative Breast Carcinoma

About this study

This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.

Interventions

• Procedure: Biospecimen Collection — Undergo blood sample collection
• Other: Medical Chart Review — Undergo medical cart review
• Procedure: Stress Management Therapy — Receive biobehavioral stress reduction intervention
• Other: Survey Administration — Ancillary studies

Primary outcomes

• Participant Satisfaction with the Biobehavioral Intervention (Up to 2 years)
• Profile of Mood States for the Biobehavioral Intervention (Up to 2 years)
• Participant Biobehavioral Intervention (Up to 2 years)

Eligibility information

Study locations

• MetroHealth, Cleveland, Ohio 44109 United States
• Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States